EGFR and non-small cell lung carcinoma: However, despite different constraints, one gene sequencing approach is still largely used with an LB, notably for EGFR status evaluation, due to the frequency of EGFR mutated NS-NSCLC, notably in Asia, and the availability of the different TKIs for treatment of patients with these tumors [28,29,30].